Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients-Reference-Cited by-同舟云学术

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients

Published:2016-11 Issue:11 Volume:6 Page:e493-e493
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

De Stefano V,Vannucchi A M,Ruggeri M,Cervantes F,Alvarez-Larrán A,Iurlo A,Randi M L,Pieri L,Rossi E,Guglielmelli P^ORCID,Betti S,Elli E,Finazzi M C,Finazzi G,Zetterberg E,Vianelli N,Gaidano G,Nichele I,Cattaneo D,Palova M,Ellis M H,Cacciola E,Tieghi A,Hernandez-Boluda J C,Pungolino E,Specchia G,Rapezzi D,Forcina A,Musolino C,Carobbio A,Griesshammer M,Barbui T

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj2016103.pdf

Reference38 articles.

1. De Stefano V, Martinelli I . Splanchnic vein thrombosis: clinical presentation, risk factors and treatment. Intern Emerg Med 2010; 5: 487–494.

2. Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson A et al. Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival—an 18-year experience. Liver Int 2009; 29: 253–259.

3. Rajani R, Björnsson E, Bergquist A, Danielsson A, Gustavsson A, Grip O et al. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther 2010; 32: 1154–1162.

4. Acosta S, Alhadad A, Svensson P, Ekberg O . Epidemiology, risk and prognostic factors in mesenteric venous thrombosis. Br J Surg 2008; 95: 1245–1251.

5. De Stefano Qi X, Betti S, Rossi E . Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment. Thromb Haemost 2016; 115: 240–249.

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations;Thrombosis Research;2024-02

2. Decreased patency of transjugular intrahepatic portosystemic shunts performed for splanchnic vein thrombosis in patients with myeloproliferative neoplasms;Thrombosis Research;2024-02

3. Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights;International Journal of Molecular Sciences;2024-01-26

4. Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology;Annals of Hematology;2024-01-24

5. Do we need more guidance on thrombophilia testing? Challenges and special considerations;Expert Review of Hematology;2024-01-16